DRUG · Mapped RxNorm record
Hydroxychloroquine
Normalized identity: hydroxychloroquineView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer
NCT06328387
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Sacituzumab Govitecan
Normalized identity: sacituzumab govitecanView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Trastuzumab Deruxtecan
Normalized identity: trastuzumab deruxtecanView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedHCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Advanced Breast Cancerunresolved
Metastatic Breast Cancerunresolved
Interventions
HydroxychloroquineDRUG · verified · RxNorm: hydroxychloroquine
Sacituzumab GovitecanDRUG · verified · RxNorm: sacituzumab govitecan
Trastuzumab DeruxtecanDRUG · verified · RxNorm: trastuzumab deruxtecan
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06328387 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.